LEVORA 0.15 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levora 0.15, and what generic alternatives are available?
Levora 0.15 is a drug marketed by Watson Labs and Dr Reddys Labs Sa and is included in two NDAs.
The generic ingredient in LEVORA 0.15 is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LEVORA 0.15?
- What are the global sales for LEVORA 0.15?
- What is Average Wholesale Price for LEVORA 0.15?
Summary for LEVORA 0.15
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | LEVORA 0.15 at DailyMed |
US Patents and Regulatory Information for LEVORA 0.15
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | LEVORA 0.15/30-21 | ethinyl estradiol; levonorgestrel | TABLET;ORAL-21 | 073592-001 | Dec 13, 1993 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Dr Reddys Labs Sa | LEVORA 0.15/30-28 | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 073594-001 | Dec 13, 1993 | AB | RX | No | Yes | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
